Pharm Exec convened a roundtable discussion during the 2016 American Society of Clinical Oncology Annual meeting to examine a central question in cancer treatment today: what is the appropriate role of patient-reported outcome (PRO) measures in driving a drug evaluation model that incorporates insights from the real-life patient experience?

Inaugural Benchmarking Data on HCP Meetings and Engagements: The Industry’s biggest challenge when managing HCP meetings and engagements. Review of the gaps and suboptimal processes and systems currently used today to compliantly manage HCP meetings and engagements.

Biopharma companies face significant complexity. This insight brief will help you learn how to align all aspects of marketed product maintenance (including regulatory, safety and benefit-risk management) to improve compliance and reduce complexity and cost.

View this infographic to see how Quintiles helps anticipate and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience and therapeutic expertise, along with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market to transform the lives of patients and their families

Quintiles is an experienced partner who can help biopharmaceutical companies simplify the complexities of rare disease studies to speed new treatments to market for patients and their families. Read this compendia featuring blogs and bylined articles from Quintiles’ experts to learn more.

Join Randolph Carpio from Quintiles, and Joe Bonaccorso from Pierre Fabre as they discuss the importance of getting the reimbursement, access and distribution strategy correct to make the most of the opportunities in the U.S.

Hundreds of new vaccines are in clinical development, yet significant barriers to progress exist. These barriers include a lack of novel approaches to help speed timelines and drive efficiencies in clinical testing of vaccines and the need for reduced R&D cost to improve the ROI of vaccine development globally. Read this fact sheet to see how Quintiles’ dedicated team of vaccine experts can help drive your vaccine studies forward.

This paper, which incorporates the results of a survey of 254 pharmaceutical executives worldwide and a range of interviews with industry experts, explores global pharmaceutical companies' growth strategies and their plans for managing the associated risks.

Emerging Pharma Leaders

Compliance Top of Mind

There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.